Filing Flows › Novartis AG (NVS) › Q1 2026 › vs Q1 2025
Novartis AG (NVS) Q1 2026 vs Q1 2025 (year over year)
Novartis AG's revenue fell $120M (-0.9%) from $13.2B in Q1 2025 to $13.1B in Q1 2026. Operating margin 32.3% against 35.2% (-2.9 pts).
Novartis AG, Q1 2026: revenue $13.1B (-0.9% year over year), operating margin 32.3%, net earnings $3.2B. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Operating margin | 32.3% | 35.2% | -2.9 pts |
| Net margin | 24.1% | 27.3% | -3.2 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $13.1B | $13.2B | −$120M | -0.9% |
| Operating profit | $4.2B | $4.7B | −$428M | -9% |
| Costs & expenses | $8.9B | $8.6B | $308M | +4% |
| Pre-tax earnings | $3.2B | $3.6B | −$453M | -13% |
| Other expense, net | $1.1B | $1.1B | $25.0M | +2% |
| Net earnings | $3.2B | $3.6B | −$453M | -13% |
Questions
How much did Novartis AG's revenue grow year over year in Q1 2026?
Novartis AG's revenue fell $120M (-0.9%) from $13.2B in Q1 2025 to $13.1B in Q1 2026. Operating margin 32.3% against 35.2% (-2.9 pts).